Ingrezza (Valbenazine Capsule) 40mg

Valbenazine works by reversibly inhibiting the vesicular monoamine transporter 2 (VMAT2), which decreases the release of dopamine and other monoamines in the brain. This action helps to reduce the symptoms of movement disorders.

The dosage of Ingrezza is determined by your doctor based on your medical condition, response to treatment, and other medications you may be taking. Always follow your doctor's instructions for the correct dosage.

The safety of Ingrezza during pregnancy or breastfeeding is not well established. It is important to discuss the potential risks and benefits with your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

To order Ingrezza from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping, and the import paperwork.

Ingrezza is a VMAT2 inhibitor specifically approved for tardive dyskinesia and Huntington’s chorea. It works by decreasing the release of dopamine in the brain. Other treatments may include anticholinergics or other medications that target different pathways. The choice of treatment depends on individual patient needs and response.

Ingrezza should be stored at room temperature away from light and moisture. Keep all medications away from children and pets. Do not store in the bathroom. Properly discard this product when it is expired or no longer needed.

Ingrezza is taken orally, usually once daily, with or without food. The capsules should be swallowed whole with a glass of water. If you have trouble swallowing, consult your doctor for alternative administration methods.

The most serious risks to watch for with Ingrezza include depression and suicidal thoughts/attempts, especially in patients with Huntington’s disease. Other serious risks include neuroleptic malignant syndrome (NMS), severe confusion, severe tiredness, muscle stiffness/pain/tenderness/weakness, and fever.

Ingrezza should not be used by individuals who are allergic to valbenazine or any of its ingredients. It should be used with caution in patients with a history of depression or suicidal thoughts, especially those with Huntington’s disease. Always consult your doctor before starting Ingrezza.